Induction of Fibrosis Regression on Patients With Chronic Hepatitis B Infection
Phase of Trial: Phase IV
Latest Information Update: 25 Sep 2015
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms INFIRE; INFIRE-001
- 10 Jun 2017 Biomarkers information updated
- 22 Sep 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 11 Aug 2012 Actual initiation date 17 Dec 2010 added as reported by EudraCT.